Blood pressure and contraceptive use
- PMID: 6809102
- PMCID: PMC1499207
- DOI: 10.1136/bmj.285.6339.403
Blood pressure and contraceptive use
Abstract
PIP: In a survey of 461 women routinely attending family planning clinics, those taking oral contraceptives had significantly higher mean systolic and diastolic blood pressures than those using non-hormonal contraception. There appeared to be a dose-response relation of blood pressure to the progestogen component of 2 oral contraceptives with an identical 30 micrograms ethinylestradiol component. This supports the idea that the progestogen as well as the estrogen component has an etiological role in the rise in blood pressure. There was a significant correlation of blood pressure with duration of current use of oral contraceptive but not with total duration of use. There was also a significant negative correlation of blood pressure with time since oral contraceptives were last taken, and women who had stopped using oral contraceptives over a month previously had similar blood pressures to those who had never taken them. In women taking oral contraceptives, those who had either a history of hypertension in pregnancy or a family history of hypertension had significantly higher mean blood pressures than those who did not. Both systolic and diastolic blood pressures correlated independently with weight and body mass index, but controlling for the effect of this and age did not affect the above relations. No significant differences in mean blood pressures were found between different ethnic groups, and there was no relation of blood pressure to reported marital state, social class, parity, smoking, or alcohol use.
Similar articles
-
Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994.J Hypertens. 1997 Oct;15(10):1063-8. doi: 10.1097/00004872-199715100-00003. J Hypertens. 1997. PMID: 9350579
-
Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure.Am J Obstet Gynecol. 1985 Jan 1;151(1):28-32. doi: 10.1016/0002-9378(85)90418-1. Am J Obstet Gynecol. 1985. PMID: 3966503
-
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.J Clin Endocrinol Metab. 1995 Jun;80(6):1816-21. doi: 10.1210/jcem.80.6.7775629. J Clin Endocrinol Metab. 1995. PMID: 7775629 Clinical Trial.
-
Drug-induced hypertension: pathogenesis and management.Drugs. 1976;12(3):222-30. doi: 10.2165/00003495-197612030-00005. Drugs. 1976. PMID: 185040 Review.
-
[Hormonal contraception].Rev Med Liege. 1992 May;47(5):221-36. Rev Med Liege. 1992. PMID: 1604074 Review. French.
Cited by
-
Prevention of coronary heart disease.Br Med J (Clin Res Ed). 1983 Oct 8;287(6398):1064-5. doi: 10.1136/bmj.287.6398.1064-b. Br Med J (Clin Res Ed). 1983. PMID: 6412948 Free PMC article. No abstract available.
-
Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.Clin Pharmacokinet. 1990 Apr;18(4):295-317. doi: 10.2165/00003088-199018040-00003. Clin Pharmacokinet. 1990. PMID: 2182265 Review.
-
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Drugs. 2000 Oct;60(4):721-869. doi: 10.2165/00003495-200060040-00003. Drugs. 2000. PMID: 11085198 Review.
-
Drug-induced cardiovascular disorders.Drug Saf. 2007;30(9):783-804. doi: 10.2165/00002018-200730090-00005. Drug Saf. 2007. PMID: 17722970 Review.
-
Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies.Curr Hypertens Rep. 2003 Dec;5(6):505-12. doi: 10.1007/s11906-003-0059-0. Curr Hypertens Rep. 2003. PMID: 14594572 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources